Earnings Call details for unaudited financial results for the second quarter and half year ended 30th September 2026.

19th October 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: SAILIFE BSE Scrip code: 544306 Dear Sir/Madam, Ref: Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Sub: Intimation of Earnings Conference call. Pursuant to Regulation 30(2) of SEBI Listing Regulations, we hereby inform you that the Company is hosting Earnings Conference call for analysts and investors on Friday, 06th November 2026, at 11:00 A.M. (IST) to discuss on the unaudited standalone and consolidated financial results of the Company for the second quarter and half year ended 30th September 2026. The dial-in details of the call are enclosed. The above information is also available on the website of the Company: https://sailife.com/financial-information/. Kindly take the above information on your record. Thanking you. Yours sincerely, For Sai Life Sciences Limited Runa Karan Company Secretary & Compliance Officer Membership No. A13721 Encl.: As above Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. Sai Life Sciences Q2FY27 Results Conference Call At 11.00 AM IST on November 6, 2026 (Friday) We are pleased to invite you to Sai Life Sciences Q2FY27 results conference call with the senior management. The conference call will be held on Friday, November 6, 2026, at 11:00 AM (IST). The call will be initiated with a brief management discussion on the earnings performance followed by an interactive Question & Answer session The details of the earnings call are: Date: November 6, 2026 | Time Slot (IST): 11:00 AM – 12:00 PM Dial-in Number: +91 22 6280 1107, +91 22 7115 8008 Other Dial in Numbers: International Toll Free: USA: 18667462133 | UK: 08081011573 | Singapore: 8001012045 | Hong Kong: 800964448 Pre-Registration Facility for the call and dial in directly without waiting for the operator: Click Here Or Copy this URL in your browser: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=2692507&linkSecurityString=17b72eb6e2 Management Representation from Sai Life Sciences Limited Mr. Krishna Kanumuri, Managing Director & Chief Executive Officer Mr. Siva Chittor, Whole-Time Director and Chief Financial Officer About Sai Life Sciences Limited Sai Life Sciences is one of India’s fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO) that partners with innovator pharmaceutical and biotech companies to accelerate the discovery, development, and commercialization of new medicines. Headquartered in Hyderabad, India, with a strong global presence, the company offers integrated solutions spanning medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms. Sai Life Sciences is committed to delivering high-quality, cost-effective, and scalable solutions while upholding the highest standards of safety, compliance, and integrity. With a focus on innovation and operational excellence, the company continues to strengthen its capabilities to support emerging therapeutic modalities and meet the evolving needs of the life sciences industry. For more information, please visit www.sailife.com For further information please contact: Investorrelation@sailife.com